These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23133340)

  • 1. Bringing clarity to the reporting of health equity.
    PLOS Medicine Editors
    PLoS Med; 2012 Oct; 9(10):e1001334. PubMed ID: 23133340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EQUATOR Network and the PRISMA Statement for the reporting of systematic reviews and meta-analyses.
    Harms M
    Physiotherapy; 2009 Dec; 95(4):237-40. PubMed ID: 19892087
    [No Abstract]   [Full Text] [Related]  

  • 4. The PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analyses.
    Cornell JE
    Ann Intern Med; 2015 Jun; 162(11):797-8. PubMed ID: 26030637
    [No Abstract]   [Full Text] [Related]  

  • 5. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRISMA statement.
    Moher D; Altman DG; Liberati A; Tetzlaff J
    Epidemiology; 2011 Jan; 22(1):128; author reply 128. PubMed ID: 21150360
    [No Abstract]   [Full Text] [Related]  

  • 7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting guidelines: CONSORT, PRISMA, and SQUIRE.
    Foster RL
    J Spec Pediatr Nurs; 2012 Jan; 17(1):1-2. PubMed ID: 22188266
    [No Abstract]   [Full Text] [Related]  

  • 10. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity.
    Welch V; Petticrew M; Tugwell P; Moher D; O'Neill J; Waters E; White H;
    PLoS Med; 2012; 9(10):e1001333. PubMed ID: 23222917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews.
    Turpin DL
    Am J Orthod Dentofacial Orthop; 2005 Dec; 128(6):681-5; discussion 686. PubMed ID: 16360902
    [No Abstract]   [Full Text] [Related]  

  • 12. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias.
    Knobloch K; Yoon U; Vogt PM
    J Craniomaxillofac Surg; 2011 Mar; 39(2):91-2. PubMed ID: 21145753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting and methodological quality of systematic reviews in the orthopaedic literature.
    Gagnier JJ; Kellam PJ
    J Bone Joint Surg Am; 2013 Jun; 95(11):e771-7. PubMed ID: 23780547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    J Clin Epidemiol; 2009 Oct; 62(10):1006-12. PubMed ID: 19631508
    [No Abstract]   [Full Text] [Related]  

  • 15. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    Phys Ther; 2009 Sep; 89(9):873-80. PubMed ID: 19723669
    [No Abstract]   [Full Text] [Related]  

  • 16. Informative reporting of systematic reviews in radiology.
    Bossuyt PM
    Radiology; 2013 Nov; 269(2):313-4. PubMed ID: 24155281
    [No Abstract]   [Full Text] [Related]  

  • 17. Compliance of systematic reviews in ophthalmology with the PRISMA statement.
    Lee SY; Sagoo H; Farwana R; Whitehurst K; Fowler A; Agha R
    BMC Med Res Methodol; 2017 Dec; 17(1):178. PubMed ID: 29281981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    Ann Intern Med; 2009 Aug; 151(4):264-9, W64. PubMed ID: 19622511
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    BMJ; 2009 Jul; 339():b2535. PubMed ID: 19622551
    [No Abstract]   [Full Text] [Related]  

  • 20. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    PLoS Med; 2009 Jul; 6(7):e1000097. PubMed ID: 19621072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.